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SUMMARY 
The Otx2 homeoprotein transcription factor is expressed in the dopaminergic neurons of the 
ventral tegmental area, a mesencephalic nucleus involved in the control of complex behaviors 
through its projections to limbic structures, including the ventral hippocampus, amygdala, 
nucleus accumbens and prefrontal cortex. We find adult mice heterozygous for Otx2 show a 
hypoanxious phenotype in light-dark box and elevated plus maze paradigms. However, the 
number of dopaminergic neurons, the integrity of their axons, their projection patterns in target 
structures, and the amounts of dopamine and dopamine metabolites in targets structures were 
not modified in the Otx2 mutant. Because OTX2 is expressed by the choroid plexus, secreted 
into cerebrospinal fluid and transferred to parvalbumin interneurons of the cortex, hippocampus, 
and amygdala, we investigated if the hypoanxiety of Otx2 heterozygous mice could result from 
the decreased synthesis of Otx2 in the choroid plexus. Indeed, hypoanxious phenotype was 
reversed by the overexpression of Otx2 specifically in choroid plexus of adult Otx2 
heterozygous mice, while hypoanxious phenotype could be induced in adult wild type mice by 
lowering OTX2 levels in the cerebrospinal fluid. Taken together, OTX2 synthesis by the 
choroid plexus followed by its secretion into the cerebrospinal fluid is an important regulator 
of the anxiety phenotype in the mouse.  
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INTRODUCTION 
Homeoprotein (HP) transcription factors are expressed during development when they 
participate in all developmental decisions, in and outside the nervous system (1). In the 
developing nervous system HPs are more specifically involved in the segmentation of the 
neuroepithelium, cell lineage decisions, cell shape and migration, and axon guidance (2). 
Interestingly, most HPs remain expressed in the adult nervous system in regions and cell types 
that differ from those identified during development and in relation with their specific and 
partially mysterious adult physiological functions (2; 3). 
 
An aspect of HP functions that has recently attracted some attention is their ability to transfer 
between cells. This intercellular transport results in non-cell autonomous HP regulation of gene 
expression and potentially induces changes in the epigenetic status of the receiving cells (3). 
Although HP transduction in vivo and in vitro was only verified for about 15 HPs, the sequences 
responsible for HP internalization and secretion are highly conserved, strongly suggesting that 
transduction is a shared property of most of the 200-300 members of the HP family (4; 5).  
 
The vertebrate orthodenticle orthologue Otx2 homeogene encoding OTX2 HP acts, early in 
development, as a gap gene for the anterior part of the central nervous system, including the 
telencephalon (6; 7). However, Otx2 expression is rapidly turned off and has already ceased in 
the mouse cerebral cortex parenchyma at embryonic day 15 (E15). In contrast, its expression 
persists throughout life in the pineal gland, choroid plexus (ChP), and in neurons within the 
septum, thalamus, cerebellum and midbrain, including the mesencephalic dopaminergic (mDA) 
neurons of the ventral tegmental area (VTA) (2). This latter observation indicates a possible 
implication in psychiatric disorders, as the VTA mDA neurons innervate several cerebral 
structures regulating complex behaviors (8; 9) and require Otx2 expression for their proper 
development and survival (10; 11). 
 
A role for Otx2 in the post-natal adult control of complex traits, such as depression or anxiety 
has recently been demonstrated by maternal separation experiments. For example, maternal 
separation of mouse pups between a critical period, ranging from postnatal day 10 (P10) to P20, 
leads to a social defeat-induced depressive adult phenotype regulated by a transient decrease in 
Otx2 expression in the VTA (12). In a separate study also involving maternal separation-
induced anxiety, it was proposed that Otx2 upregulation in the ChP and OTX2 transfer to 
ventral hippocampus inhibitory interneurons may participate in the anxiety phenotype (13).  
 
In the latter context, it must be recalled that OTX2 expressed in the ChP is secreted into the 
cerebrospinal fluid (CSF) and transported to the brain parenchyma where it is primarily 
captured by the fast-spiking GABAergic parvalbumin neurons (FSPV cells) (14). This capture 
is favored by the presence within OTX2 of a sequence (the RK-peptide) that recognizes specific 
extracellular glycosaminoglycans present in the perineural nets (PNNs) that enwrap FSPV cells 
in layers III and IV of the cerebral cortex (15; 16).  
 
During mouse late postnatal development, the privileged accumulation of OTX2 within FSPV 
cells in the visual cortex opens plasticity for binocular vision at P20 and closes it by P40 (17). 
This critical period of plasticity is thus regulated by non-cell autonomous OTX2, a phenomenon 
that was recently extended to the auditory cortex and medial prefrontal cortex (mPFC) (18). 
For the visual cortex, it was also shown that pharmacological or genetic decreases of FSPV cell 
OTX2 content in the adult cortex reopens a window of plasticity, allowing for the recovery of 
binocular vision in mice made amblyopic by the closure of one eye during the juvenile critical 
period (14; 15).  
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The accumulation of ChP-derived OTX2 in layers III/IV FSPV cells throughout the adult cortex 
suggests that this transfer may regulate complex behaviors. This hypothesis is supported by 
recent studies in the Otx2-AA mouse line in which the arginine-lysine (RK) doublet of the RK-
peptide necessary for addressing OTX2 specifically to FSPV cells was mutated into two 
alanines (AA doublet). This RK->AA mutation slows down OTX2 accumulation in FSPV cells 
throughout the cerebral cortex. This delays the maturation of the primary auditory cortex and 
the mPFC, resulting in prolonged acquisition of acoustic preference in adulthood linked to 
anxiolysis (18).  
 
In the present study, we have taken advantage of the Otx2 heterozygote mouse line (Otx2-het) 
in which one Otx2 allele is replaced by GFP leading to a decrease in Otx2 expression (19). We 
find that lowered Otx2 expression modifies anxiety-related behaviors and that anxiety is 
regulated by secretion of OTX2 at the level of the ChP. 
 
MATERIAL AND METHODS 
Ethics statement 
All animal procedures, including housing, were carried out in accordance with the 
recommendations of the European Economic Community (86/609/EEC), the French National 
Committee (87/848) and French bylaws (AGRG1240332A / AGRG1238724A / 
AGRG1238767A / AGRG1238729A / AGRG1238753A). For surgical procedures, animals 
were anesthetized with Xylazine (Rompun 2%, 5 mg/kg) and Ketamine (Imalgene 500, 80 
mg/kg). This research (project no. 00704.02) was approved by Ethics committee n° 59 of the 
French Ministry for Research and Higher Education. 
 
Mice 
The Otx2-het mouse line was generated in the laboratory of Antonio Simeone (CEINGE, 
Naples), with the Otx2 coding sequence and introns replaced by GFP (20). Otx2+/GFP males 
were crossed with B6D2F1 females to obtain Otx2-het mice. The single-chain antibody (scFv) 
OTX2 knock-in scFv-Otx2 mouse line was generated by the Institut Clinique de la Souris 
(Strasbourg, France) by inserting the scFv-Otx2 minigene construct in the Rosa26 locus (21). 
Mice were raised in a 12-hour light/dark cycle with 2 to 5 (males) or 6 (females) animals per 
cages. Temperature was controlled (21±3°C), and food and water provided ad libitum.  
 
AAV injections 
Adeno-associated viruses (AAV) were generated by Vector Biolabs: AAV5(CMV)-HAOtx2-
2A-mCherry and AAV5(CMV)-mCherry. Stereotaxic injections were performed with a 
Hamilton syringe at a rate of 0.3 µl/min: 2 µl/lateral ventricle (bregma: x = ±1.28 mm, y = -
0.58 mm, z = 2 mm). Mice were tested in the light-dark box and on the elevated-plus maze 3 
and 4 weeks after injection, respectively. 
 
Cre-TAT protein injection 
Stereotaxic injection (bregma: x = -0.58 mm, y = ±1.28 mm, z = 2 mm) of Cre-TAT in 15% 
DMSO into the lateral ventricles of anesthetized mice was performed with a Hamilton syringe 
at a rate of 0.2 µl/min as previously described (14). Mice were tested in the elevated-plus maze 
4 weeks after injection. 
 
Behavior 
Tests were performed from P90 to P120 in groups of female or male WT and Otx2-het mice in 
the following order: locomotor activity, Y-maze, elevated-plus maze, light-dark box, rotarod, 
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tail-suspension, prepulse inhibition, forced swimming test. Except for rotarod, tail-suspension 
and prepulse inhibition tests, behavior was registered using a semi-automated infrared system 
(Viewpoint, Lyon). 
  
Y maze 
Short-term spatial memory and locomotor activity was evaluated by the spontaneous alternative 
exploration of the Y-maze during 10 min. The maze consisted of 3 alleys diverging at 120° 
from one another, 40 cm long, 15 cm width, with black 30 cm high Perspex borders decorated 
differently in each arm, which were illuminated at 50 lux. The mouse was placed at the tip of 
one arm and the time spent visiting each of the other arms sequentially was counted as a 
memory performance. 
 
Elevated-plus maze  
A cross-shape maze elevated at 70 cm from the floor was illuminated at 50 lux. Two “closed” 
arms facing each other and protected by black Perspex walls (20 cm high), are crossed 
perpendicularly by the two “opened” unprotected arms. The mouse was placed at the center of 
the cross and activity was recorded for 10 min. The time spent in the open arms taken as an 
index of low anxiety.  
 
Light-dark box 
Boxes are composed of a dark (black walls, floor and roof) and light (white walls and floor, no 
roof, 150 lux) compartments of equal volume (20 x 20 x 30 cm) linked by a small opening. The 
mouse is placed in the light box facing the opening, and anxiety is measured by the time spent 
in the dark compartment over a 10 min test. 
 
Rotarod 
Equilibrium and motor coordination were measured in a progressively accelerating (from 2 to 
40 rpm during 5 min) rotarod (model 47600, Ugo Basile, Italy). Each daily test included 3 trials 
separated by 90 min intervals, during 2 days.  
 
Tail-suspension test 
Mice were suspended by the tail with adhesive linked to a gauge detecting movement 
(automated system BIOSEB, France), during 6 min. Immobility was interpreted a sign of 
depression. 
 
Forced swimming test 
This test evaluates depressive behaviors by registering the periods of freezing of mice placed 
in a see-through Perspex cylinder full of water (25°C). The cylinder is 25 cm high, 13 cm in 
diameter and filled up to 20 cm. On the first day, the mice were habituated to the test during 10 
min, on the second day the test lasted 6 min. An infrared panel positioned vertically behind the 
cylinder detects mice movements. Immobility was interpreted a sign of depression. 
 
Prepulse Inhibition test 
Testing was carried out in a SR-Lab system (San Diego Instruments, USA). Each mouse was 
placed in a startle chamber. Acoustic noise bursts were presented via a speaker mounted 26 cm 
above the tube. Throughout the session, a background noise level of 68 dB was maintained. 
After a 5-min acclimatization period (68 dB background noise), 10 startle pulses (120 dB, 40 
ms duration) were presented with an average inter-trial interval of 15 s. During the next 20 min, 
no stimulus (background noise, 68 dB), prepulses alone (72, 76, 80 or 84 dB, 20 ms duration), 
startle pulses alone, and prepulses followed 80 ms later by startle pulses were presented 10 
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times, randomly distributed. Percent prepulse inhibition (PPI) was calculated as [100 – 
100x(startle response of acoustic startle from acoustic prepulse and startle stimulus 
trials)/(startle response alone trials)]. 
 
Dosage of cerebral amines and their metabolites 
Brains were dissected in ice-cold PBS and dry tissue was kept at -80°C. Extracts were prepared 
and analyzed by HPLC using a reverse phase column (Nucleosil 120-3 C18; Knauer) with 
electrochemical detection as described (22). Data were recorded and quantified using HPLC 
Chromeleon computer system (Dionex).  
 
Immunohistochemistry 
Anesthetized mice were perfused transcardially with 20 ml of PBS and 30 ml of 4% 
paraformaldehyde (10 ml/min). Dissected brains were post-fixed in 4% paraformaldehyde at 
4°C for 1 h, rinsed in PBS, soaked in 20% sucrose at 4°C for 12-24 h and frozen. Fluorescent 
immunohistochemistry was performed on cryostat sections (20 µm). Briefly, after 
permeabilization with 1% Triton for 20 min, sections were incubated in 100 mM Glycine for 
20 min, blocked with PBS, 0.2% Triton, 10% normal goat serum (NGS) for 45 min and 
incubated overnight with primary antibodies: anti-tyrosine hydroxylase antibody (rabbit, abcam, 
1/500); anti-dopamine transporter (rat, Millipore, 1/5000); anti-c-Fos (rabbit, Cell Signaling, 
1/200); anti-parvalbumin (rabbit, Swant, 1/500); anti-tryptophan hydroxylase 2 (rabbit, abcam, 
1/500) in PBS, 1% Triton, 3% NGS at 4°C. After 3 washes in PBS, 1% Triton, secondary 
antibodies were used (Alexa Fluor-conjugated, Molecular Probes) for 2 h at room temperature 
(1/2000). After 3 washes in PBS, 1% Triton, sections were mounted in Dapi-fluoromount 
medium and kept at 4°C. DAB Immunohistochemistry was performed on free-floating cryostat 
sections (40 µm). Endogenous peroxidase was removed with a 5 min incubation in 0.3% H2O2, 
0.2% Methanol. Sections were permeabilized and blocked as above and incubated during 12-
24h with an anti-tyrosine hydroxylase antibody (rabbit, Pel Freeze Biologicals, 1/1000) in PBS, 
0.1% Triton, 3% NGS at 4°C. After 3 washes in PBS, 0.1% Triton, a biotin-coupled anti-rabbit 
antibody (1/2000) was added for 2h at room temperature. After 3 washes in PBS, 0.1% Triton, 
biotin was detected by using the Vectastain Elite ABC HRP kit and Peroxidase Substrate kit 
(1h of ABC buffer + reaction with DAB) from Vectorbiolabs and the slides washed in ddH2O.  
 
Cell counting and fibers density 
Images from the immunohistochemistry sections were acquired with a Leica SP5 confocal 
microscope at 10X or 40X and analyzed with FIJI/ImageJ. For the VTA cell counting, every 
second section (containing VTA) was counted by stereology using Stereo Investigator software 
(MBF Bioscience Inc.) at a 40X magnification. Amygdala was imaged between Bregma -1.7 
mm and -2.60 mm. Confocal z-stacks covering the whole depth of the sections were taken with 
3 µm step size and only subsets of confocal planes with the optimal penetration level for each 
antibody were selected. After z-projection of stacks, the basolateral amygdala area was selected 
and measured and the number of cells was determined in the area for each marker and the 
density of the staining was assessed by the mean grey value option of FIJI.  
 
Statistical Analysis 
All statistics were performed using GraphPad Prism (version 8.1.2, GraphPad Software). In 
order to avoid type II errors, outliers were defined as more than 2 standard deviations from the 
group mean and were removed from analysis. Main effects and interactions with more than 2 
groups were determined using analyses of variance (ANOVA) or 2-way ANOVA with Tukey’s 
multiple comparison post hoc test. Student’s t test was used for single comparisons among two 
groups. An alpha level of 0.05 was used for all statistical tests.  
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RESULTS 
Otx2-heterozygote mice present low anxiety-related behaviors 
Three-month-old Otx2-het (one allele of Otx2) and their wild-type siblings were analyzed for 
motor coordination (rotarod), depression (tail-suspension and forced swimming tests), 
cognition (Y-maze), sensorimotor gating (prepulse inhibition) and anxiety (openfield, light-
dark box and elevated-plus maze). Motor coordination measured by the rotarod test showed 
differences between males and females (F(3.270)=28.50 p<0.0001), but not between WT and 
Otx2-het animals (Figure 1A). Depression measured by the forced swimming (Figure 1B) and 
tail suspension (Figure 1C) tests showed no differences between the two genotypes and a small 
difference between males and females in the tail suspension test only (77.09 ± 12.84 vs 39.09 
± 5.41; F(1.52)=10.40 p=0.0022), with females being more depressed than males. The short-
term spatial memory test (Y maze) was used to measure both locomotor activity and memory. 
Although females show a slightly higher motor activity (4944 ± 130 vs 4439 ± 160; 
F(1.54)=4.75 p=0.0337), here again no differences were found between the two phenotypes 
(Figure 1D). Another absence of difference between genotypes was found in the prepulse 
inhibition (PPI) test (Figure 1E), although the startle amplitude was a bit higher in mutant males 
at 120 decibels only (38.60 ± 5.19 vs 71.87 ± 13.27 p<0.0001). All in all, it can be concluded 
that the loss of one Otx2 allele does not affect motor activities, cognition, depression behavior 
or sensorimotor gating.  
 
 In contrast, strong differences between WT and Otx2-het mice appeared in the light-dark box 
(LDB) and the elevated plus maze (EPM) anxiety tests (Figure 2A, B). Otx2-het mice spent 
more time than WT in the lit compartment of the LDB (58.84 ± 9.64 vs 115.93 ± 13.87; 
F(1.57)=11.34 p=0.0014) as well as in the open arms of the EPM (6.00 ± 1.44 vs 46.13 ± 8.71; 
F(1.52)=18.49 p<0.0001). These effects are similar in both sexes as revealed by the absence of 
significant sex x genotype effect in each test (Figure 2B). The EPM test was also conducted in 
absence of light (Figure 2C) ensuring that the hypo-anxious behavior associated with the loss 
of one Otx2 allele is independent of a putative vision deficit created by decreased Otx2 
expression (6.86 ± 1.78 vs 25.34 ± 5.67; F(1.42)=10.09 p=0.0028). The EPM anxiety test was 
thereafter used as an anxiety read-out in all experiments.  
 
The low anxiety behavior of Otx2-het mice in the EPM test does not reflect a dopaminergic 
or serotoninergic phenotype 
In a previous study, it was found that mice heterozygous for Engrailed-1, a homeogene 
expressed in the mDA neurons of the ventral midbrain, experience a progressive loss of these 
neurons in the Substantia Nigra (SNpc) and VTA beginning at 6 weeks. This results in a 40% 
and 20% neuronal loss at 48 weeks in the SNpc and VTA, respectively (23). Otx2 is expressed 
in the adult VTA (11), and the projections of the VTA into several target structures, including 
the hippocampus, nucleus accumbens, amygdala, and the mPFC may be involved in anxiety 
regulation (12). This led us to analyze the hypoanxiety behavior of Otx2-het mice between 1 
and 4 months of age, including the age at which behavior was tested (3 months). Figure 2D 
illustrates that the hypoanxiety behavior is established very early and is maintained during this 
period, making it unlikely that it is due to mDA progressive neuronal loss (F(3.229)=56.06 
p<0.0001; 1 mo p=0.03; 2 mo p=0.0019; 3 mo p=0.032; 4 mo p<0.0001). 
 
The latter conclusion was further confirmed by stereology counting of tyrosine hydroxylase 
(TH)-positive cell bodies of the VTA (Figure 3A) which showed no differences between 3-
month-old Otx2-het animals and their WT siblings. However as illustrated in a study on SNpc 
mDA neurons in WT and Engrailed-1 heterozygotes, cells bodies can be present while axons 
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begin degenerating as characterized by their fragmentation, clearly visible both in the medial 
forebrain bundle and in the striatum (24). Hence, we evaluated the state and density of the TH- 
and dopamine transporter (DAT)-positive fibers in the basolateral amygdala, a region 
responsible for the fear response and receiving mDA terminals from the VTA (25). No 
significant changes were observed neither for the density of any of the two markers of 
dopaminergic neurotransmission, nor for the morphology of the fibers (Figure 3C, D).  
 
To further evaluate a possible dopaminergic phenotype, dopamine (DA) and its main 
metabolites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were 
measured in the cortex (anterior and posterior), the striatum, and the hippocampus of 3-month-
old WT and Otx2-het mice from the same litter (Figure 3B). The amounts are very similar in 
both genotypes and in all studied structures, thus eliminating both a change in absolute DA 
concentrations and in DA metabolism.  
Early Otx2 hypo-morphism can also lead to an increase in the number serotonin (5HT) neurons 
by an anterior shift in the midbrain/hindbrain boundary (26; 27). Because 5HT has is implicated 
in anxiety regulation (28; 29), we measured the levels of 5HT and of its main metabolite 5HIAA. 
We found no differences between animals of either genotype and in any of the studied structures 
(Figure 3E). Furthermore, the serotoninergic fibers in the amygdala marked with the TPH2 
antibody showed similar morphology and density in both WT and Otx2-het mice (Figure 3C, 
D).  
 
Otx2 synthesized in the ChP and released into the CSF regulates mouse anxiety 
In postnatal mice, Otx2 is expressed in several extra-cortical structures, including the VTA and 
ChP (12; 14) but no expression takes place in the cerebral cortex parenchyma (17). Although 
not expressed in the cerebral cortex, OTX2 is imported from extra-cortical structures, in 
particular ChP, by neurons throughout the cortex (primarily PV cells), including limbic 
structures (14; 18). In addition to all studied cortical regions, including the mPFC, non-cell 
autonomous OTX2 can be identified in hippocampus CA1, and basolateral amygdala (14). 
Because of this presence of OTX2 in several structures implicated in the regulation of anxiety-
related behaviors, we developed gain- and loss-of-function experiments to evaluate the possible 
contributions of the ChP to the regulation of anxiety behavior.  
 
Adeno-associated virus-5 (AAV5) injected into the lateral ventricles (Figure 4A) gains 
specifically access to ChP (14) allowing a 1.5 fold overexpression of  Otx2 in this structure 
(t=3.525; p=0.0023) (Figure 4B). This overexpression resulted in a tendency of increased 
anxiety in the hypo-anxious phenotype of Otx2-het mice in the EPM test (Figure 4C, p=0.067). 
Despite the lack of significance, this experiment suggests that Otx2 expression in the ChP is 
sufficient to restore a normal anxiety behavior in the Otx2-het mouse.  
  
ChP do not only clean the CSF from toxic metabolites acting as the ‘kidney of the brain’, but 
also nurture the brain by secreting into the CSF a large number of trophic factors (30; 31), 
including Otx2 (14). The restoring effect of expressing Otx2 in the ChP could thus result from 
the cell autonomous transcription of genes encoding factors secreted into the CSF and/or from 
the direct secretion of OTX2 into the CSF, similarly to what has been demonstrated in critical 
periods paradigms (14; 18; 21). To reinforce the ChP gain of function experiment (Figure 4C) 
and verify if OTX2 secreted by the ChP could regulate anxiety behavior, we took advantage of 
a mouse line expressing a secreted scFv directed against OTX2 (21). In this mouse, injection 
of a cell-permeable Cre recombinase in the brain ventricles induces the secretion of the scFv-
OTX2 antibody at the level of the ChP (21). This leads to the neutralization of extracellular 
OTX2 in the CSF and, in the case of the visual cortex, to the reopening of plasticity (21). As 
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illustrated in Figure 4D, neutralizing ChP-derived OTX2 in the CSF installs a hypo-anxious 
phenotype in 3-month-old mice (t=2.120; p=0.039). 
 
DISCUSSION 
In this study, we provide evidence for a role of Otx2 in the regulation of anxious behavior and 
that OTX2 secreted from the ChP into the CSF plays a role in this regulation. This does not 
exclude other extra-cortical sources, in particular the pineal gland, but establishes that the ChP, 
through the synthesis and secretion of OTX2 is an important anxiety regulator. Anxiety 
regulation can be the consequence of modest changes in OTX2 expression and/or secretion. For 
expression, the AAV5 strategy induces a 50% increase in ChP Otx2 transcription. For secretion, 
previous studies using the same neutralization strategy in the CSF showed that a 20% OTX2 
decrease in the visual cortex FSPV cells is sufficient to reopen plasticity in the adult (21). In 
the present study, target structures were not identified, but it can be claimed that an acute 
decrease of OTX2 en route from the ChP to the brain parenchyma of 3-month-old mice is 
enough to decrease anxiety. This result excludes that Otx2-het mice hypoanxiety is purely 
developmental, as also suggested by the similar hypo-anxious behavior of mice at 1, 2, 3 and 4 
months of age. 
 
As just mentioned, non-cell autonomous OTX2 target cells and structures were not investigated. 
In such complex behaviors, it is likely that several interacting structures are implicated. If so, 
the presence of OTX2 in the CSF could give the protein access to many candidate target 
structures functioning in association through the existence of neuronal networks and hub 
structures (32; 33). This is apparently the case as non-cell autonomous OTX2 was found in PV 
cells from the mPFC, hippocampus and amygdala (13; 14). Interestingly, recent experiments 
strongly suggest that OTX2 imported in PNN-enwrapped FSPV cells in the mPFC and in the 
ventral hippocampus might regulate anxiety (13; 18). Although the accent here is placed on PV 
cells, other interneurons might play an Otx2-associated role as suggested in the mPFC where 
OTX2 is mainly imported by PV+ and calretinin+ interneurons (70% and 20% co-labeling, 
respectively) (18).  
 
The large repertoire of anxiety-related interconnected target structures is also shared by 
projections from the VTA(8; 9). Since Otx2 is expressed in the adult VTA and may regulate 
the survival of the mDA cells that constitute 65% of the neuronal population in this structure 
(34), a possible cell autonomous role of OTX2 on VTA mDA neuron physiology/survival or, 
alternatively, a non-cell autonomous effect on their hippocampal of cortical targets following 
anterograde transport and trans-synaptic passage cannot not be excluded. The experiments 
demonstrating that the number of mDA neurons is not affected in the mutant at 3 months of age 
(the hypo-anxious phenotype is present already at 1 months and persists at least for 3 more 
months) is not in favor of the idea that mDA neuron number is at the origin of the phenotype. 
In addition, we found no change in the amount of DA and DA metabolites in the cortex, 
hippocampus and striatum, further supporting the view that the mDA “phenotype” is not altered 
in Otx2-het mice. Nor did we find any change in 5HT innervation or the amount of 5HT and of 
its metabolite 5HIAA as expected if the early Otx2 hypomorphism had shifted the 
midbrain/hindbrain boundary in a more anterior position (26; 27).  
 
However, the results from Nestler and colleagues (12), establishes a role for cell autonomous 
Otx2 in the VTA, independently of the number of mDA neurons or of DA levels and 
metabolism. They showed that a transient decrease in Otx2 expression between P10 and P20 in 
mDA neurons of the VTA can trigger a depressive state in adulthood following social defeat. 
Our finding that overexpression Otx2 in the ChP can reduce anxiety in the adult suggests that 
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the mechanisms involved in the present hypo-anxiety phenotype either differs from those at 
work in the maternal separation paradigm or that a link exists between Otx2 expression in the 
VTA during a critical period (here from P10 to P20) and the ability of the ChP to direct OTX2 
to non-cell autonomous target structures. Results from the Gould and colleagues further support 
this possibility (13). They observed a parallel increase of OTX2 in the ChP and in ventral 
hippocampus PV cells of mice made hyperanxious through early maternal separation.  
 
Together, the findings from the Nestler, Gould and our labs encourages us to propose a model 
outlined in Figure 5. We hypothesize that Otx2 expression, at the mRNA and protein level, in 
VTA mDA neurons constitutes a first trigger for an enhanced transfer into target PV cells 
(ventral hippocampus, mPFC, or other region) of OTX2 from extra-cortical sources, including 
ChP. Conversely an abnormal decrease in Otx2 expression during a critical period would 
jeopardize the proper development of mood-associated circuits. This is very reminiscent of how 
eye opening at P14 in the mouse is followed by a transient critical period in the binocular visual 
cortex, the opening and duration of which is regulated by extra-cortical OTX2. The trigger that 
comes from the eye at P14 is dependent on OTX2 in the retina (17), suggesting that OTX2 
locally regulates the expression of factors acting on subcortical and cortical structures or, and 
non-exclusively, is itself transported to visual cortex PV cells (35; 36). The latter view is 
supported by the finding that recombinant OTX2 injected in the eye can reach PV cells in the 
visual cortex (35). Whatever the signals might be, we speculate that they provoke the first 
assembly of PNNs allowing for further import of OTX2 from extra-cortical sources (15). In 
brief, the VTA would play the role in the early regulation of complex behaviors that the eyes 
play in the regulation of plasticity in the primary visual cortex. Given the huge body of literature 
on sensory system plasticity, this hypothesis, if confirmed by future experiments, would foster 
new views on the study of “mood” regulation and disease.   
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FIGURE LEGENDS 
 
Figure 1. Behavioral phenotype characterization of the Otx2-het mice.  
Male and female WT or Otx2-het mice were subjected to numerous behavior tests between P90 
and P120. (A) The rotarod test measured the latency to fall (sec) from a progressively 
accelerating rotating rod from 2 to 40 rpm during 5 min trial (WT females n=16; WT males 
n=18; Otx2-het females n=10; Otx2-het males n=14). (B) Forced swim test measured total time 
immobile (sec) during a 6 min period in a small pool (WT females n=16; WT males n=17; 
Otx2-het females n=10; Otx2-het males n=14). (C) Tail suspension test measured total time 
immobile (sec) during a 6 min period (WT females n=16; WT males n=17; Otx2-het females 
n=10; Otx2-het males n=15). (D) Total locomotor activity (min) and amount of time spent in 
alternative arms (in %) were measured in the Y-maze during 10 min (WT females n=16; WT 
males n=17; Otx2-het females n=10; Otx2-het males n=15). (E) Prepulse inhibition (PPI) test 
performed in a startle chamber to measure startle response amplitude (lower panels) and PPI 
(%, upper panels) (WT females n=16; WT males n=18; Otx2-het females n=10; Otx2-het males 
n=14). Data are presented as mean ± SEM.: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 
0.0001 (two-way ANOVA, post hoc: Tukey´s test). 
 
Figure 2. Anxiety phenotype characterization of the Otx2-het mice.  
(A) The light-dark box test measured time (sec) spent in light box during a 10 min period (WT 
females n=15; WT males n=16; Otx2-het females n=16; Otx2-het males n=14). (B) Total time 
(sec) spent in open arms in the elevated plus maze during a 10 min period (WT females n=15; 
WT males n=15; Otx2-het females n=15; Otx2-het males n=14). (C) Elevated plus maze 
performed in normal (50 lux) or dark (0 lux) conditions (WT light n=13; WT dark n=12; Otx2-
het light n=11; Otx2-het dark n=12).  (D) Elevated plus maze at different ages (from 1 month 
to 4 months) (WT 1 mo n=44; WT 2 mo n=39; WT 3 mo n=16; WT 4 mo n=33; Otx2-het 1 mo 
n=32; Otx2-het 2 mo n=35; Otx2-het 3 mo n=22; Otx2-het 4 mo n=31). Data are presented as 
mean ± SEM.: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 (two-way ANOVA, post 
hoc: Tukey´s test). 
 
Figure 3. Dopaminergic and serotoninergic markers are not disturbed in the Otx2-het 
mice.  
(A) Immunohistochemistry for tyrosine hydroxylase (TH) in the Otx2-het (n=4) and WT (n=5) 
mice for quantification of VTA dopaminergic cells. Scale bar: 50 µm. (B) Quantification of 
metabolites related to the dopaminergic system (DA, Dopamine; DOPAC, 3,4-
Dihydroxyphenylacetic acid; HVA, Homovanillic acid) in the anterior (Cx ant) and posterior 
cortices (Cx post), striatum (Str) and hippocampus (Hipp) (WT n=5; Otx2-het n=7). (C) 
Staining of fibers with dopamine (DAT, dopamine transporter; TH, tyrosine hydroxylase) and 
serotonin (TPH2, Tryptophan hydroxylase 2) in the basolateral amygdala in the Otx2-het and 
WT mice. Scale bar: 250 µm. (D) Quantification of DAT, TH and TPH2 fibers in the basolateral 
amygdala (WT n=6; Otx2-het n=7). (E) Quantification of metabolites related to the 
serotoninergic system (5HT, serotonin transporter; 5HIAA, 5-hydroxyindoleacetic acid) in the 
anterior (Cx ant) and posterior cortices (Cx post), striatum (Str) and hippocampus (Hipp) (WT 
n=5; Otx2-het n=7). Data are presented as mean ± SEM (student´s t test). 
 
Figure 4. Otx2 overexpression in ChP rescues the hypoanxious phenotype in the Otx2-het 
mice.  
(A) Schematic representation of the injection of AAV5(CMV)-HAOtx2-2A-mCherry virus in 
the ChP. In the image, the infected cells of the ChP expressing the fluorescent mCherry marker 
(white) compared to the control animals. Scale bar: 100 µm. (B) qRT-PCR of (mRNA) Otx2 
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(normalized by GAPDH) in the ChP tissue after 3-weeks viral expression (AAV-ctrl n=9; 
AAV-HAOtx2 n=12). (C) Time spent in open arms (sec) during a 10 min trial in the elevated 
plus maze for the control mice (WT; n=12), the Otx2-het mice injected in the ChP with control 
virus (AAV-ctrl; n=13) and the Otx2-het mice injected in the ChP with virus overexpressing 
Otx2 (AAV-HAOtx2; n=11). (D) Time spent in open arms (sec) during a 10 min trial in the 
elevated plus maze for the mutants expressing the single-chain antibody against OTX2 (scFv-
Cre-Tat; n=23) and the controls not expressing the antibody (scFv-NaCl; n=34). Data are 
presented as mean ± SEM: #p = 0.067; *p < 0.05; **p < 0.01 (student´s t test or ANOVA). 
 
Figure 5. Hypothetical scheme for a VTA, limbic structures and ChP interaction  
The model proposes that Otx2 in the VTA is upregulated in response to synaptic inputs or 
systemic signals (e.g. hormonal signals). Although this is not represented in this simplified 
illustration, the VTA is highly heterogeneous with compartments projecting to different 
structures (e.g anterior cingulate cortex, ventral hippocampus, amygdala, nucleus 
accumbens…) (25) and all compartments probably do not respond to similar signals in Otx2 
regulation. The general principle is that, responding to the latter signals [Panel 1], Otx2 is 
upregulated and, either directly (35) or through the regulation of targets informs the 
corresponding limbic structures [Panel 2], more precisely the PV cells which, in response, 
assemble PNNs [Panel 3]. The latter assembly allows for OTX2 from extra-cortical sources 
(here the ChP) to recognize its binding sites within the PNNs (15), to enter the PV cells [Panel 
4] and provoke their maturation. In the adult the permanent entry of OTX2 is necessary to 
maintain a differentiated state (2). Indeed, adult gain of OTX2 expression or neutralization of 
extracellular OTX2 at the level of the ChP modifies the anxiety phenotype of the mice (this 
study). In this hypothetical scheme based on studies on visual cortex critical period and adult 
plasticity (2), a specific traumatism modifying Otx2 expression in a VTA sub-compartment (for 
example maternal separation between a P10 and P20 critical period in the mouse) (12) may 
leave a permanent epigenetic trace on the functioning of physiologic circuits (37). 
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